Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Changes of bone density in pediatric patients with β-thalassemia major after allogenic hematopoietic stem cell transplantation.

Hamidieh AA, Hamidi Z, Nedaeifard L, Heshmat R, Alimoghaddam K, Larijani B, Ghavamzadeh A, Mohajeri-Tehrani MR.

Arch Iran Med. 2013 Feb;16(2):88-92. doi: 013162/AIM.008.

2.

Comparison of bone mineral density changes in pediatric thalassemic patients with and without hematopoietic stem cell transplant.

Hamidieh AA, Mohajeri-Tehrani MR, Behfar M, Vaghari-Meher N, Alimoghaddam K, Mohseni F, Ghavamzadeh A, Larijani B, Hamidi Z.

Exp Clin Transplant. 2015 Apr;13(2):173-8. doi: 10.6002/ect.2014.0178. Epub 2014 Nov 12.

3.

Relation between BMD and biochemical, transfusion and endocrinological parameters in pediatric thalassemic patients.

Mohseni F, Mohajeri-Tehrani MR, Larijani B, Hamidi Z.

Arch Osteoporos. 2014;9:174. doi: 10.1007/s11657-014-0174-3. Epub 2014 Mar 21.

PMID:
24652076
4.

Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients.

Caocci G, Baccoli R, Vacca A, Mastronuzzi A, Bertaina A, Piras E, Littera R, Locatelli F, Carcassi C, La Nasa G.

Exp Hematol. 2010 May;38(5):426-33. doi: 10.1016/j.exphem.2010.02.012. Epub 2010 Mar 4.

PMID:
20206661
5.

Bone mineral density and calcium metabolism in adolescents with beta-thalassemia major.

Tantawy AA, El Kholy M, Moustafa T, Elsedfy HH.

Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:132-5.

PMID:
19337166
6.

Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study.

Gandhi MK, Lekamwasam S, Inman I, Kaptoge S, Sizer L, Love S, Bearcroft PW, Milligan TP, Price CP, Marcus RE, Compston JE.

Br J Haematol. 2003 May;121(3):462-8.

PMID:
12716369
7.

Bone mineral density in beta-thalassemia major and intermedia.

Karimi M, Ghiam AF, Hashemi A, Alinejad S, Soweid M, Kashef S.

Indian Pediatr. 2007 Jan;44(1):29-32.

8.

Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugs.

Di Stefano M, Chiabotto P, Roggia C, Garofalo F, Lala R, Piga A, Isaia GC.

J Bone Miner Metab. 2004;22(1):53-7.

PMID:
14691688
9.

Regional bone mineral density after orthotopic liver transplantation.

Hussaini SH, Oldroyd B, Stewart SP, Roman F, Smith MA, Pollard S, Lodge P, O'Grady JG, Losowsky MS.

Eur J Gastroenterol Hepatol. 1999 Feb;11(2):157-63.

PMID:
10102226
10.

Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.

Colao A, Di Somma C, Loche S, Di Sarno A, Klain M, Pivonello R, Pietrosante M, Salvatore M, Lombardi G.

Clin Endocrinol (Oxf). 2000 Mar;52(3):319-27.

PMID:
10718830
11.

Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.

Ebeling PR, Thomas DM, Erbas B, Hopper JL, Szer J, Grigg AP.

J Bone Miner Res. 1999 Mar;14(3):342-50.

12.

Bone health evaluation of children and adolescents with homozygous β-thalassemia: implications for practice.

Doulgeraki A, Athanasopoulou H, Voskaki I, Tzagaraki A, Karabatsos F, Fragodimitri C, Georgakopoulou E, Iousef J, Monopolis I, Chatziliami A, Karagiorga M.

J Pediatr Hematol Oncol. 2012 Jul;34(5):344-8. doi: 10.1097/MPH.0b013e3182431ddb.

PMID:
22395221
13.

Low bone mass in prepubertal children with thalassemia major: insights into the pathogenesis of low bone mass in thalassemia.

Vogiatzi MG, Autio KA, Schneider R, Giardina PJ.

J Pediatr Endocrinol Metab. 2004 Oct;17(10):1415-21.

PMID:
15526720
14.

Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation.

Caocci G, Efficace F, Ciotti F, Roncarolo MG, Vacca A, Piras E, Littera R, Dawood Markous RS, Collins GS, Ciceri F, Mandelli F, Marktel S, La Nasa G.

Biol Blood Marrow Transplant. 2011 Jun;17(6):861-6. doi: 10.1016/j.bbmt.2010.09.011. Epub 2010 Sep 24.

15.

Bone mineral density changes within 11 months of renal transplantation in Iranian patients.

Bayat N, Einollahi B, Pourfarzian V, Alishiri G, Nemati E, Bagheri N, Miri SM, Elizeii PK.

Transplant Proc. 2007 May;39(4):1039-43.

PMID:
17524886
16.

Bone mineral density in long-term survivors following pediatric liver transplantation.

Guthery SL, Pohl JF, Bucuvalas JC, Alonso MH, Ryckman FC, Balistreri WF, Heubi JE.

Liver Transpl. 2003 Apr;9(4):365-70.

17.

Bone mineral density in ex-thalassemic pediatric patients.

Hamidieh AA, Hamidi Z, Nedaeifard L, Heshmat R, Haralambous H, Alimoghaddam K, Larijani B, Ghavamzadeh A, Mohajeri-Tehrani MR.

Hematol Oncol Stem Cell Ther. 2012;5(1):70-1. doi: 10.5144/1658-3876.2012.71. No abstract available.

18.

HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: the experience of the Turkish Pediatric Bone Marrow Transplantation Group.

Yesilipek MA, Ertem M, Cetin M, Öniz H, Kansoy S, Tanyeli A, Anak S, Kurekci E, Hazar V.

Pediatr Transplant. 2012 Dec;16(8):846-51. doi: 10.1111/j.1399-3046.2012.01778.x. Epub 2012 Aug 29.

PMID:
22931438
19.

Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.

Dodidou P, Bruckner T, Hosch S, Haass M, Klar E, Sauer P, Ziegler R, Leidig-Bruckner G.

Osteoporos Int. 2003 Jan;14(1):82-9.

PMID:
12577189
20.

Lumbar spine bone mineral density in diabetic children with recent onset.

De Schepper J, Smitz J, Rosseneu S, Bollen P, Louis O.

Horm Res. 1998;50(4):193-6.

PMID:
9838239

Supplemental Content

Support Center